How the US Food and Drug Administration's approval of aducanumab for Alzheimer's disease has implication for oncology and beyond. (November 2021)

Record Type:
Journal Article
Title:
How the US Food and Drug Administration's approval of aducanumab for Alzheimer's disease has implication for oncology and beyond. (November 2021)
Main Title:
How the US Food and Drug Administration's approval of aducanumab for Alzheimer's disease has implication for oncology and beyond
Authors:
Lythgoe, Mark P.
Prasad, Vinay
Abstract:
Is Part Of:
European journal of cancer. Volume 157(2021)
Journal:
European journal of cancer
Issue:
Volume 157(2021)
Issue Display:
Volume 157, Issue 2021 (2021)
Year:
2021
Volume:
157
Issue:
2021
Issue Sort Value:
2021-0157-2021-0000
Page Start:
68
Page End:
70
Publication Date:
2021-11
Subjects:
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:
http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.ejca.2021.08.012 ↗
Languages:
English
ISSNs:
0959-8049
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
19629.xml